Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease

BACKGROUND: Perceived risks of hyperkalemia and acute renal insufficiency may limit use of mineralocorticoid receptor antagonist (MRA) therapy in patients with heart failure, especially those with diabetes mellitus or chronic kidney disease. METHODS AND RESULTS: Using clinical registry data linked t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Cooper, Lauren B., Lippmann, Steven J., Greiner, Melissa A., Sharma, Abhinav, Kelly, Jacob P., Fonarow, Gregg C., Yancy, Clyde W., Heidenreich, Paul A., Hernandez, Adrian F.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5779000/
https://ncbi.nlm.nih.gov/pubmed/29275368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006540
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars